BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
26.04.24
/
50%
€75.64
Target price
26.04.25
€104.69
Performance (%)
-26.63%
End price
27.04.25
€55.50
Summary
This prediction ended on 27.04.25 with a price of €55.50. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -26.63%. Morgan_Stanley has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.851% | -1.851% | -19.691% |
| iShares Core DAX® | 0.794% | 2.841% | 22.630% |
| iShares Nasdaq 100 | 0.016% | -0.939% | 6.943% |
| iShares Nikkei 225® | 0.309% | -0.648% | 13.619% |
| iShares S&P 500 | 0.181% | -0.442% | 4.692% |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $115.00 to $112.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€48.80
03.07.25
03.07.25
€82.17
03.07.26
03.07.26
4.30%
30.12.25
30.12.25
Stopped prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.90
28.10.25
28.10.25
€84.06
28.10.26
28.10.26
8.53%
30.12.25
30.12.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.36
22.07.25
22.07.25
€82.12
22.07.26
22.07.26
1.07%
30.12.25
30.12.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€113.91
01.08.24
01.08.24
-3.59%
02.08.24
02.08.24

